Adjuvant effect of argatroban on staphylokinase induced thrombolysis of platelet rich thrombi in rat mesenteric venules in vivo

Thrombosis Research

Volumn 86, Issue 2, 1997, Pages 115-126

  Kawano, Makiko ^a   Watanabe, Sadahiro ^b   Sasaki, Yasuto ^a   Giddings, John C ^c   Yamamoto, Junichiro ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b KOBE CITY COLLEGE OF NURSING   (Japan)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Argatroban; Staphylokinase; Thrombolysis; Thrombosis

Indexed keywords

ARGATROBAN; RECOMBINANT STAPHYLOKINASE; STAPHYLOKINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG POTENTIATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE; THROMBOSIS;

ANIMALS; ANTITHROMBINS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; METALLOENDOPEPTIDASES; MICROSCOPY, ELECTRON; PIPECOLIC ACIDS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; THROMBOSIS;

EID: 0030972269     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00055-8     Document Type: Article

References (36)

1. FOLTS, J.D., CROWELL, E.B. and ROWE, G.G. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 54, 365-370, 1976.
2. HASKEL, E.J., PRAGER, N.A., SOBEL, B.E.and ABENDSCHEIN, D.R. Relative efficacy of anti thrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion. Circulation 83, 1048-1056, 1991.
3. GOLD, G.K., YASUDA, T., JANG, I., GUERRERO, J.L., FALLON, F.T., LEINBACH, R. C.and COLLEN, D. Animal models for arterial thrombolysis and prevention of reocclusion. Circulation 83 [suppl IV ]: IV 26- IV -40, 1991.
4. STRONY, J., SONG, A., RUSTERHOLTZ, L. and ADELMAN, B. Aurintricarboxylic acid prevents acute rethrombosis in a canine model of arterial thrombosis. Arterioscler Thromb Vasc Biol 15, 359-366, 1995.
5. HIRATA, Y., UMEMURA, K., TAKIGUCHI, Y. and NAKASHIMA, M. A thrombosis model for evaluating thrombolytic agents, staphylokinase, on thrombolytic activity. Blood Coagul Fibrinolysis 4, 569-575, 1993.
6. KAWASAKI, T., KAKU, S., TAKENAKA, T., YANAGI, K. and OHSHIMA, N. Thrombolytic activity of YM866, a novel modified tissue-type plasminogen activator, in a photochemically induced platelet rich thrombosis model. J Cardiovasc Pharmacol 23, 884-889, 1994.
7. MELLOTT, M.J., CONNOLLY, T.M., YORK S.J. and BUSH, L.R. Prevention of reocclusion by MCI-9038, a thrombosis. Thromb Haemost 64, 526-534, 1990.
8. SCHNEIDER, J. Heparin and thrombin inhibitor argatroban enhance fibrinolysis by infused or bolus-injected saruplase (r-scu-PA) in rabbit femoral artery thrombosis. Thromb Res 64, 677-689, 1991.
9. STOCKMANS, F., DECKMYN, H., GRUWEZ, J., VERMYLEN, J.and ACLAND, R. Continuous quantitative monitoring of mural, platelet-dependent, thrombus kinetics in the crushed rat femoral vein. Thromb Haemost 65, 425-431, 1991.
10. EDIT, J.F., ALLISON, P., NOBLE, S., ASHTON, J., GOLINO, P., MCNATT, J., BUJA, L. M. and WILLERSON, J. T. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 84, 18 27, 1989.
11. HANSON, S.R. and HARKER, L. A. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Proc Natl Acad Sci 85, 3184-3188, 1988.
12. JANG, I., GOLD, H.K., ZISKIND, A.A., LEINBATH R.C., FALLON, J.T. and COLLEN, D. Prevention of platelet rich arterial thrombosis by selective thrombin inhibition. Circulation 81, 219-225, 1990.
13. YAMASHITA, T., YAMAMOTO, J., SASAKI, Y. and MATSUOKA, A. Theantithrombotic effect of low molecular weight synthetic thrombin inhibitor argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels. Thromb Res 69, 93-100, 1993.
14. KOVACS, I.B., TIGYI-SEBES, A., TROMBITAS, K. and GOROG, P. Evans blue: An ideal energy-absorbing material to produce intravascular microinjury by He-Ne gas laser. Microvasc Res 10, 107-124, 1975.
15. YAMAMOTO, J., IIZUMI, H., HIROTA, R., SHIMONAKA, K., NAGAMATSU, Y., HORIE, N. and MORITA, S. Effect of physical training on thrombotic tendency in rats: decrease in thrombotic tendency measured by the He-Ne laser-induced thrombus formation method. Haemostasis 19, 260-265, 1989.
16. SASAKI, Y., MORII, S., YAMASHITA, T. and YAMAMOTO, J. Antithrombotic effect of argatroban of the pial vessels of the rat: a study with He-Ne laser-induced thrombus formation. Haemostasis 23, 104-111, 1993.
17. YAMASHITA, T., MATSUOKA, A., FUNATSU, A. and YAMAMOTO, J. The antithrombotic effect of human activated protein C on He-Ne laser-induced thrombosis in rat mesenteric microvessels. Thromb Res 75, 33-40, 1994.
18. SATO, M. and OHSHIMA, N. Platelet thrombus induced in vivo by filtered light and fluorescent dye in mesenteric microvessels of rat. Thromb Res 35, 319-334, 1984.
19. POVLISHOCK, J.T. and ROSENBLUM, W.I. Injury of brain microvessels with a helium neon laser and evans blue can elicit local platelet aggregation without endothelial denudation. Arch Pathol Lab Med 111, 415-421, 1987.
20. YAMAMOTO, J., ISHII, I., OKADA, Y., YAMASHITA, T., RIDLER, C.D., GOROG, P. and KOVACS, I.B. Effect of leucocyte products on platelet thrombus formation, coagulation and spontaneous thrombolysis, as measured from native human blood, in vitro. Thromb Res 71, 281-287, 1993.
21. CERLETTI, C., EVANGELISTA, V., MOLINO, M. and de GAETANO, G. Platelet activation by polymorphonuclear leukocytes: Role of cathepsin G and P-Selectin. Thromb Haemost 74, 218-223, 1995.
22. FURIE, B. and FURIE, B.C. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: Role of P-Selectin and the P-Selectin ligand, PSGL-1. Thromb Haemost 74, 224-227, 1995.
23. RUF, A. and PATSCHEKE, H. Platelet-induced neutrophil activation: platelet-expressed fibrinogen induces the oxidative burst in neutrophils by an interaction with CD II C/CD18. Br J Haematol 90, 791-796, 1995.
24. NAGAMATSU, Y., FUKUDA, A., YAMAMOTO, J., TSUDA, Y. and OKADA, Y. Quantification of leucocyte elastase and cathepsin G in plasma by a simple method. Effect of elastase in plasma levels of D-dimer and thrombomodulin. Clin Lab Haematol 18, 29-34, 1996.
25. SAKO, T. Overproduction of staphylokinase in Esherichia coli and its characterization. Ann J Biochem 149, 557-563, 1985.
26. SAKAI, M., WATANUKI, M. and MATSUO, O. Mechanism of fibrin-specific fibrinolysis by staphylokinase. Biochem Biophys Res Commun 162, 830-837, 1989.
27. MATSUO, O., OKADA, K., FUKAO, H., TOMIOKA, Y., UESHIMA, S., WATANUKI, M. and SAKAI, M. Thrombolytic properties of staphylokinase. Blood 76, 925-929, 1990.
28. LIJNEN, H.R., HOEF, B. V., COCK, F.D., OKADA, K., UESHIMA, S., MATSUO, O. and COLLEN, D. On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J Biol Chem 266, 11826-11832, 1991.
29. FITZGERALD, D.J., CATELLA, F., ROY, L. and FITZGERALD, G.A. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 77, 142-150, 1988.
30. ARONSON, D.L., CHANG, P. and KESSELER, C.M. Platelet-dependent thrombin generation after in vitro fibrinolytic treatment. Circulation 85, 1706-1712, 1992.
31. HERAS, M., CHESEBRO, J.H., WEBSTER, M.W.I., MRUK J.S., GRILL, D.E., PENNY, W. J., BOWIE, E. J. W., BADIMON, L. and FUSTER, V. Hirudin, heparin, and placebo during deep arterial injury in the pig. Circulation 82, 1476-1484, 1990.
32. HARKER, L.A., HANSON, S.R. and RUNGE, M.S. Thrombin hypothesis of thrombus generation and vascular lesion formation. Am J Cardiol 75, 12B-17B, 1995.
33. 2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proc Natl Acad Sci 86, 7585-7589, 1989.
34. IMURA, Y., STASSEN, J., VREYS, I., LESAFFRE, E., COLD, H.K. and COLLEN, D. Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model. Thromb Haemost 68, 336-340, 1992.
35. CHESEBRO, J.H., ZOLDHELYI, P., BADIMON, L. and FUSTER, V. Role of thrombin in arterial thrombosis: Implications for therapy. Thromb Haemost 66, 1-5, 1991.
36. COLLEN, D. and WERF, F.V. Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarction. Circulation 87, 1850-1853, 1993.